Print

Featured Studies Results

Cancer: Breast

Evaluating the Benefit of Adding ART6043 to Olaparib for HER2-Negative Metastatic or Advanced Breast Cancer and a BRCA Mutation (POLKA)

https://www.facingourrisk.org/research-clinical-trials/study/430 /evaluate-the-benefit-of-adding-art6043-to-olaparib-for-her2-negative-metastatic-or-advanced-breast-cancer-and-a-gbrca-mutation-polka

Clinicaltrials.gov identifier:
NCT05898399 (https://clinicaltrials.gov/show/NCT05898399)

Treatment
Metastatic breast cancer treatment study


Research Study on the Genetics of Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/317 /research-study-on-the-genetics-of-breast-cancer

Clinicaltrials.gov identifier:
NCT06773897 (https://clinicaltrials.gov/show/NCT06773897)

Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States


ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/447 /eradicate-hormone-and-targeted-therapy-for-hrher2-low-advanced-breast-cancer

Clinicaltrials.gov identifier:
NCT07198724 (https://clinicaltrials.gov/show/NCT07198724)

Treatment
Study of hormone and targeted therapy for advanced breast cancer


Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

https://www.facingourrisk.org/research-clinical-trials/study/443 /low-dose-tamoxifen-with-or-without-omega-3-fatty-acids-for-breast-cancer-risk-reduction

Clinicaltrials.gov identifier:
NCT06195306 (https://clinicaltrials.gov/show/NCT06195306)

Prevention
Prevention study for postmenopausal women at increased risk for breast cancer


IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer

https://www.facingourrisk.org/research-clinical-trials/study/266 /helping-people-with-a-genetic-mutation-in-brca1-brca2-or-lynch-syndrome-talk-to-their-family-members-about-their-risk-for-cancer-and-find-the-best-way-to-get-family-members-tested

Clinicaltrials.gov identifier:
NCT07318363 (https://clinicaltrials.gov/show/NCT07318363)

Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested


ShareForCures®: Komen's People-Powered, Data-Driven Breast Cancer Research Registry

https://www.facingourrisk.org/research-clinical-trials/study/295 /shareforcures-susan-g-komens-people-powered-data-driven-breast-cancer-research-registry

Clinicaltrials.gov identifier:
NCT05654246 (https://clinicaltrials.gov/show/NCT05654246)

Surveys, Registries, Interviews
Registry for anyone diagnosed with breast cancer


Share Your Experience with Psychotherapy After a Hereditary Breast Cancer Diagnosis

https://www.facingourrisk.org/research-clinical-trials/study/455 /psychotherapy-for-hereditary-breast-cancer-patients

Surveys, Registries, Interviews
Survey and interview for hereditary breast cancer patients in therapy


Virtual Exercise Classes for Adult Cancer Survivors (SURGE)

https://www.facingourrisk.org/research-clinical-trials/study/445 /virtual-exercise-classes-for-adult-cancer-survivors-surge

Clinicaltrials.gov identifier:
NCT07290309 (https://clinicaltrials.gov/show/NCT07290309)

Quality of Life
Exercise study for people diagnosed within the past 5 years


Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

https://www.facingourrisk.org/research-clinical-trials/study/438 /using-a-computer-model-to-identify-treatment-options-in-advanced-metastatic-breast-cancer-synthesis-breast

Clinicaltrials.gov identifier:
NCT07067138 (https://clinicaltrials.gov/show/NCT07067138)

Treatment
Treatment study for people with metastatic breast cancer


REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis

https://www.facingourrisk.org/research-clinical-trials/study/423 /rekindle-your-ability-to-cope-with-a-life-changing-medical-diagnosis

Clinicaltrials.gov identifier:
NCT07002034 (https://clinicaltrials.gov/show/NCT07002034)

Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness


Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study

https://www.facingourrisk.org/research-clinical-trials/study/394 /multi-cancer-detection-blood-tests-in-adults-without-cancer-vanguard-study

Clinicaltrials.gov identifier:
NCT06995898 (https://clinicaltrials.gov/show/NCT06995898)

Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer


A Study of the Drug Romosozumab in People With Metastatic Breast Cancer and Osteoporosis

https://www.facingourrisk.org/research-clinical-trials/study/433 /a-study-of-the-drug-romosozumab-in-people-with-metastatic-breast-cancer-and-osteoporosis

Clinicaltrials.gov identifier:
NCT07776613 (https://clinicaltrials.gov/show/NCT07776613)

Quality of Life
Study for people with metastatic breast cancer and osteoporosis


Psilocybin Therapy in Advanced Cancer

https://www.facingourrisk.org/research-clinical-trials/study/436 /psilocybin-therapy-in-advanced-cancer

Clinicaltrials.gov identifier:
NCT05398484 (https://clinicaltrials.gov/show/NCT05398484)

Quality of Life
Study for people with advanced cancer


Please Help us Learn More About Immunotherapy Side Effects That People With Cancer Experience

https://www.facingourrisk.org/research-clinical-trials/study/421 /a-5-minute-patient-and-caregiver-survey-to-share-experiences-with-immunotherapy-and-any-short-term-or-long-term-side-effects

Surveys, Registries, Interviews
Survey on immunotherapy to share experiences, including side effects and whether they were resolved or not


A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advanced or Metastatic Breast Cancer who Progressed After a Prior Line of Treatment

https://www.facingourrisk.org/research-clinical-trials/study/414 /a-study-to-learn-about-the-study-medicine-called-pf-07248144-in-combination-with-fulvestrant-in-people-with-hr-positive-her2-negative-advanced-or-metastatic-breast-cancer-who-progressed-after-a-prior-line-of-treatment

Clinicaltrials.gov identifier:
NCT07062965 (https://clinicaltrials.gov/show/NCT07062965)

Treatment
Study for adults with advanced/metastatic HR-positive, HER2-negative breast cancer who have progressed from prior treatment


Testing the Drug CX-5461 for Treating Metastatic Solid Tumors

https://www.facingourrisk.org/research-clinical-trials/study/431 /testing-the-drug-cx-5461-for-treating-metastatic-solid-tumors

Clinicaltrials.gov identifier:
NCT06606990 (https://clinicaltrials.gov/show/NCT06606990)

Treatment
Phase 1 study for treatment of advanced solid tumors


Testing a New Targeted Therapy ETX-19477 to Treat Advanced Breast, Colorectal Endometrial, Ovarian or Pancreatic Cancer in People with a BRCA2 Mutation (ERADIC8)

https://www.facingourrisk.org/research-clinical-trials/study/432 /testing-a-new-targeted-therapy-etx-19477-to-treat-advanced-solid-tumors-eradic8

Clinicaltrials.gov identifier:
NCT06395519 (https://clinicaltrials.gov/show/NCT06395519)

Treatment
Treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer


Evaluating the Safety of Nipple Sparing Mastectomy in Women With a High Risk for Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/392 /evaluating-the-safety-of-nipple-sparing-mastectomy-in-women-with-a-high-risk-for-breast-cancer

Clinicaltrials.gov identifier:
NCT06888388 (https://clinicaltrials.gov/show/NCT06888388)

Prevention
Study for people considering double mastectomy to reduce breast cancer risk


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.